Ullet index:WAKAMOTO PHARMACEUTICAL CO.,LTD.:4512

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index WAKAMOTO PHARMACEUTICAL CO.,LTD. Go to web site 4512 Medicals 東証スタンダード March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

WAKAMOTO PHARMACEUTICAL CO.,LTD. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 11,610
plusdown
12,026
plusup
11,907
plusup
11,481
plusup
11,386
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 64
plusdown
109
plusdown
138
plusdown
239
plusup
-602
plus
Operating Cash Flow(OFC)Help -592
plusdown
-107
plusdown
632
plusup
339
plusup
163
plus
Free Cash Flow(FCF)Help -606
plusdown
-110
plusdown
649
plusup
390
plusup
-36
plus
OFC - Net IncomeHelp 47
plusdown
47
plusdown
47
plusdown
52
plusup
50
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -10.74%
plusdown
-1.93%
plusdown
11.39%
plusup
6.60%
plusup
3.67%
plus
Current Assets / Amount of SalesHelp 70.81%
plusdown
72.04%
plusup
64.07%
plusup
61.28%
plusup
50.07%
plus
Free Cash Revenue RatioHelp -7.78%
plusdown
-1.42%
plusdown
7.49%
plusup
4.65%
plusup
-0.41%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

WAKAMOTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

CHUKYOIYAKUHIN CO.,LTD.
PRISM BioLab
KYORIN Pharmaceutical Co., Ltd.
SANTEN PHARMACEUTICAL CO.,LTD.
ZERIA PHARMACEUTICAL CO.,LTD.
Veritas In Silico
WAKAMOTO PHARMACEUTICAL CO.,LTD.
SEIKAGAKU CORPORATION
StemRIM Inc.
TSUMURA & CO.